Introduction: Primary cutaneous follicle center lymphoma (PCFCL) is the most common subtype of primary cutaneous B-cell lymphoma and is typically an indolent malignancy with an excellent prognosis. However, atypical presentations may mimic soft tissue sarcoma or high-grade lymphoma, creating significant diagnostic challenges. Case Report: In this report, we describe a unique case of a young male with a history of systemic lupus erythematosus (SLE) who presented with a slowly enlarging, ulcerated soft-tissue mass of the lower back with associated drainage, pain, fever, and weight prompting treatment with dose-adjusted R-EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) loss. Upon admission, cross-sectional imaging and fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography–computed tomography (PET-CT) revealed a large (15 cm) right dorsal soft tissue mass with intense FDG uptake. Core needle biopsy initially demonstrated a high-grade appearing B-cell lymphoma with a concern for high grade lymphoma. Following additional immunostaining and multidisciplinary hematopathology review, the diagnosis was revised to PCFCL with a diffuse growth pattern. The patient completed four cycles of inpatient chemotherapy with a reduction in mass size after each cycle. Conclusion: Here we present a case of PCFCL with a diffuse growth pattern that mimicked both soft-tissue sarcoma and high-grade B-cell lymphoma, highlighting the importance of prompt tissue diagnosis and comprehensive pathologic evaluation.
No takes yet. Share an insight, caveat, or question.
Agarwal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: